We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade
Read MoreHide Full Article
In the latest trading session, Cardinal Health (CAH - Free Report) closed at $246.45, marking a -2.02% move from the previous day. This change lagged the S&P 500's 0.6% gain on the day. Elsewhere, the Dow saw an upswing of 0.03%, while the tech-heavy Nasdaq appreciated by 1.18%.
The prescription drug distributor's stock has climbed by 14.19% in the past month, exceeding the Medical sector's gain of 2.23% and the S&P 500's loss of 0.79%.
The investment community will be paying close attention to the earnings performance of Cardinal Health in its upcoming release. The company is slated to reveal its earnings on November 5, 2026. The company's upcoming EPS is projected at $2.92, signifying a 14.51% increase compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $66.96 billion, up 4.6% from the prior-year quarter.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $12.55 per share and revenue of $266.02 billion, indicating changes of +11.46% and +4.63%, respectively, compared to the previous year.
Investors should also pay attention to any latest changes in analyst estimates for Cardinal Health. Such recent modifications usually signify the changing landscape of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Cardinal Health is currently sporting a Zacks Rank of #3 (Hold).
In terms of valuation, Cardinal Health is currently trading at a Forward P/E ratio of 20.05. This represents a premium compared to its industry average Forward P/E of 17.7.
It's also important to note that CAH currently trades at a PEG ratio of 1.51. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. As the market closed yesterday, the Medical - Dental Supplies industry was having an average PEG ratio of 2.1.
The Medical - Dental Supplies industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 159, positioning it in the bottom 36% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade
In the latest trading session, Cardinal Health (CAH - Free Report) closed at $246.45, marking a -2.02% move from the previous day. This change lagged the S&P 500's 0.6% gain on the day. Elsewhere, the Dow saw an upswing of 0.03%, while the tech-heavy Nasdaq appreciated by 1.18%.
The prescription drug distributor's stock has climbed by 14.19% in the past month, exceeding the Medical sector's gain of 2.23% and the S&P 500's loss of 0.79%.
The investment community will be paying close attention to the earnings performance of Cardinal Health in its upcoming release. The company is slated to reveal its earnings on November 5, 2026. The company's upcoming EPS is projected at $2.92, signifying a 14.51% increase compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $66.96 billion, up 4.6% from the prior-year quarter.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $12.55 per share and revenue of $266.02 billion, indicating changes of +11.46% and +4.63%, respectively, compared to the previous year.
Investors should also pay attention to any latest changes in analyst estimates for Cardinal Health. Such recent modifications usually signify the changing landscape of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Cardinal Health is currently sporting a Zacks Rank of #3 (Hold).
In terms of valuation, Cardinal Health is currently trading at a Forward P/E ratio of 20.05. This represents a premium compared to its industry average Forward P/E of 17.7.
It's also important to note that CAH currently trades at a PEG ratio of 1.51. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. As the market closed yesterday, the Medical - Dental Supplies industry was having an average PEG ratio of 2.1.
The Medical - Dental Supplies industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 159, positioning it in the bottom 36% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.